Zurück
  • Abstract Talk
  • AT 02

Improvement of efficacy and safety of SARS-CoV-2 RNA-replicon vaccine candidates using immunomodulatory miRNAs and miRNA-restricted tissue-specific tropism

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Sala Koncertowa

Session

Molecular biology of SARS-CoV-2

Themen

  • Immune response to virus infection
  • SARS -CoV2 and other coronaviruses

Mitwirkende

Ricardo Requena Platek (Madrid / ES), Melissa Belló Pérez (Madrid / ES), Jesus Hurtado-Tamayo (Madrid / ES), Professor Luis Enjuanes (Madrid / ES), Dr. Isabel Sola Gurpegui (Madrid / ES)

  • © Conventus Congressmanagement & Marketing GmbH